Zydus Wellness nod to Rs 1100 crore fund-raising
New Delhi: FMCG firm Zydus Wellness on Thursday said its board has approved plans to raise up to Rs 1,099.98 crore through a combination of issuance of shares to its promoter Zydus Family Trust on a preferential basis and other options.
In a regulatory filing, Zydus Wellness said its board gave its approval "to issue, offer and allot equity shares on a preferential basis" to Zydus Family Trust. The board has accorded approval to raise Rs 349.98 crore through issuance of 21,30,000 shares at a price of Rs 1,643.10 per share.
Further, the board has also approved raising funds up to Rs 750 crore by issuing securities of the company, including equity shares (or equivalent instruments including but not limited to compulsorily convertible debentures, non-convertible debentures with warrants) through a private placement or qualified institutions placements (QIP) to qualified institutional buyers (QIBs) or a combination thereof.
The company said its board has decided to convene an extraordinary general meeting of the members of the company on September 19, 2020, to seek the approval of the members for the proposed fund raising activities.
As of quarter ended June 30, 2020, Zydus Family Trust held 4.29 per cent stake in Zydus Wellness.
Zydus Wellness offers brands such as Complan, Sugar Free, Nutralite and Everyuth.
Read also: Zydus Wellness Net Profit Rises 11 Per Cent At Rs 89 Crore In June Quarter
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.